Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Press Iceland.
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
GlobeNewswire, Inc.
·
August 19, 2024
Company Announcement TEPKINLY is the first and only subcutaneous bispecific antibody approved as a monotherapy in the European Union to treat both relapsed or refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL),...
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 25 million sales milestone payment to Basilea
GlobeNewswire, Inc.
·
September 6, 2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, September 6, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Rising Consumer Demand for Seafood Fuels Market Growth: Key Driver Transforming the Bivalve Market in 2025
EIN Presswire
·
March 31, 2025
Seafood Fuels Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at...
GDMining Introduces New Cloud Mining Plans Tailored for Beginners
GlobeNewswire, Inc.
·
September 5, 2024
St Asaph, Wales, Sept. 05, 2024 (GLOBE NEWSWIRE) -- GDMining, a premier cloud mining platform, has launched new mining plans designed specifically for beginners. With entry-level options starting at just $50, these plans provide an accessible and...
Advanced Wound Care Market Share 2025, Size Estimation, Industry Demand, Forthcoming Status and Forecast to 2034
EIN Presswire
·
December 9, 2024
Advanced Wound Care Market Size Poised to Hit USD 14.69 Billion by 2032, Driven by a 5.6% CAGR 224 W 35TH ST STE 500, NY, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Global Advanced Wound Care Market 2024 report dependent on the...
GDMining Expands Global Reach with Free Cloud Mining Service, Pioneering Accessible and Sustainable Bitcoin Mining
GlobeNewswire, Inc.
·
August 26, 2024
St Asaph, United Kingdom, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The cryptocurrency market continues to captivate and evolve, and in the heart of St Asaph, United Kingdom, GDMining is at the forefront of this transformation. GDMining is offering a...
Oculis to Present at Upcoming September Investor Conferences
GlobeNewswire, Inc.
·
August 29, 2024
ZUG, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending...
European Commission Decision to approve the pediatric use of antifungal Cresemba® (isavuconazole) and extension of market exclusivity triggers CHF 10 million milestone payment to Basilea
GlobeNewswire, Inc.
·
August 27, 2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 27, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and...
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
GlobeNewswire, Inc.
·
August 15, 2024
Dr. Klier brings significant experience in ophthalmology and drug development with a proven track record in U.S. FDA approvals, which will be instrumental as the company advances its late-stage pipeline Appointment further expands Oculis’...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
GlobeNewswire, Inc.
·
August 21, 2024
Allschwil, Switzerland, August 21, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the...
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
GlobeNewswire, Inc.
·
July 29, 2024
XEMBIFY is the first and only 20% subcutaneous immunoglobulin (SCIg) with FDA-approved dosing for treatment-naïve patients, enabling them to go straight to SCIg without initial intravenous therapy Approval, which also includes biweekly dosing,...
Travere Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire, Inc.
·
August 1, 2024
Received 521 new patient start forms (PSFs) for FILSPARI® (sparsentan) in the quarter representing the sixth consecutive quarter of PSF growth; Total of 2,484 PSFs received since launch Net product sales of FILSPARI totaled $27.1 million for the...
Century Aluminum Names Veteran Executive Peter Trpkovski Chief Financial Officer
GlobeNewswire, Inc.
·
March 21, 2025
CHICAGO, March 21, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) announced today that its Board of Directors has appointed Peter Trpkovski to be the Company’s next Executive Vice President and Chief Financial Officer. As CFO,...
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
GlobeNewswire, Inc.
·
July 22, 2024
Launch of European-made Uzpruvo in Europe comes immediately upon expiry of exclusivity rights for the molecule used to treat certain conditions in gastroenterology1, dermatology and rheumatology Creates competition at earliest opportunity,...
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2024
GlobeNewswire, Inc.
·
November 13, 2024
Haverford, PA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU), operates a diversified financial technology services company offering several different lines of business, including a business unit that provides financial...
Electric Vehicle Market is Expected To Reach a Value of US$ 1,639.84 Billion by 2034 | Fact.MR Report
GlobeNewswire, Inc.
·
August 12, 2024
Rockville, MD, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Fact.MR, a market research and competitive intelligence provider, states in its new report that the global electric vehicle market is projected to reach a size of US$ 442.34 billion in 2024 and...
Freight and Logistics Market Report: Insights, Challenges, and Future Prospects | Exactitude Consultancy
GlobeNewswire, Inc.
·
November 18, 2024
Luton, Bedfordshire, United Kingdom, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The freight and logistics sector play’s a crucial role in the global economy by ensuring the smooth movement of goods from producers to consumers. This extensive industry...
Air Traffic Control Market Projected Grows From $11.0 Billion in 2023 to $24.7 Billion by 2033
EIN Presswire
·
March 3, 2025
In December 2023, Thales Group, a leader in aerospace, defense, security, and digital identity, established an Air Traffic Management Service Center in Mexico. WILMINGTON, NEW CASTLE, DE, UNITED STATES, March 4, 2025 /EINPresswire.com/ --...
Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire, Inc.
·
July 30, 2024
ZUG, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be...
Junshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For Toripalimab
GlobeNewswire, Inc.
·
July 26, 2024
SHANGHAI, July 26, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of...